Niacin and Niacinamide Market Forecast, Trend Analysis & Competition Tracking - Global Market Insights 2019 to 2027

Published on : Oct-2019 | List of Tables : 137 | List of Figures : 63 | No. of Pages : 170 | Report Code : FACT4290MR | Format : ppt pdf Excel Word

Wide Application of Niacin and Niacinamide in Treating Various Diseases

Niacin is an organic compound with the chemical formula C6H5NO2 and is a form of Vitamin B3. In humans, Niacin deficiency can cause pellagra. Hence, it is one of the most important nutrients for humans. Niacinamide, also known as Nicotinamide or nicotinic acid amide, is interchangeably used with niacin in the realm of essential supplements. Naturally, these are found in meat, beans, fish, eggs, yeast, and green vegetables. Niacin and niacinamide may be produced in different forms including powder, granular, and liquid. These chemicals are widely accepted for a number of end uses such as human nutrition, pharmaceuticals, animal nutrition, cosmeceuticals, and others. The global niacin and niacinamide market is expected to witness a CAGR of ~5% in terms of value over the forecast period (2019-2027). Focus of established players towards exploring the application area of niacin and niacinamide and dedicated strategies have been found as trending factors in the global niacin and niacinamide market. Furthermore, increasing healthcare expenditure, inclination of consumers towards healthy eating styles, increasing demand for cosmeceutical products, and benefits of niacin and niacinamide against number of diseases are factors pushing the global niacin and niacinamide market growth. However, significant side effects associated with niacin are projected to impede the niacin and niacinamide market growth over the forecast period.

Optimal Daily Doses of Niacin and Niacinamide (Vitamin B3) for Disease Prevention Will Fuel the Growth of its Market

Niacin and niacinamide are proven to be advantageous against various diseases including Pellagra, Melanoma, etc. Taking into account severe disorders such as Schizophrenia, these chemicals have provided noticeable results, and researchers are emphasizing on the intake of niacin and niacinamide to fight against Schizophrenia. Schizophrenia is characterized by the combination of perceptual changes such as hallucinations and thought disorders such as delusions. The primary cause of schizophrenia is biochemical imbalance. Schizophrenic toxin is an oxidized derivative of an adrenaline – Adrenochrome. To reduce Adrenochrome production, researchers across the globe are emphasizing on consuming niacinamide (vitamin B3). Previously employed for treating pellagra, a disease that is indistinguishable from schizophrenia, niacinamide comprises of relevant biochemical properties. Oxidized nicotinamide adenine dinucleotide (NAD) and reduced nicotinamide adenine dinucleotide + hydrogen (NADH) forms in a human body comprise of vitamin B3, a precursor of niacinamide. There is enough availability of NAD and NADH support reconversion of oxidized adrenaline to adrenaline. The process continues to occur, and it provides sufficient niacinamide coenzymes. Therefore, provision of vitamin B3 supplements such as niacinamide to all schizophrenic patients, including acute as well as chronic patients, is essential in maintaining a healthy life. The practice further holds potential to provide significant hope of a sustainable life among schizophrenic patients, thereby, necessitating adherence of clinicians to this safe and effective treatment. Such treatments will bring about a paradigm shift in niacin and niacinamide market.

niacin and niacinamide market analysis by region

For more exhaustive analysis on the regional landscape of the niacin and niacinamide market, request for report sample here

Niacin Supplementation Complements Milk Production and Reduces Ketosis in Dairy Cattle

The application of niacin and niacinamide for enhancing animal nutrition accounts for ~60% of the market in terms of volume in 2018. Niacin and niacinamide have proven to be beneficial in terms of reducing “Ketosis” in dairy cattle, which help in higher milk production. Several high, milk-producing cattle exhibit borderline ketosis in early lactation. However, high production causes strain on the manifested energy metabolism in elevated blood ketone and reduced blood-glucose levels in these animals. Closely linked with improving energy metabolism, niacin and niacinamide (vitamin B3) represents several benefits for persistence production of milk in dairy cattle. Therapeutic doses are meant to increase milk production, along with alleviated blood changes. According to several lactation trials, cows that are supplemented with niacin are consistently producing relatively more milk with higher fat percentages, albeit with a slight difference. Small doses of niacin supplements during or after peak lactation are expected to prevent physiological symptoms associated with ketosis in dairy cattle.

Adverse Side Effects Associated with Consumption of Niacin

Other than providing various benefits against number of diseases and being a major drug for cholesterol therapy, niacin and its amide are no longer advised to be prescribed to patients. Adverse side effects and risks related to the consumption of these chemicals are restricting the adoption of niacin and niacinamide. Niacin, which proved to be advantageous in reducing heart attacks and strokes, is seen to be less effective nowadays. Research studies over the past decade have shown that the aging population who consumed doses of niacin and niacinamide have not shown any significant results in terms of reduced heart attacks and stroke rates. Niacin was used for proliferating High Density Lipoprotein (HDL) cholesterol levels to reduce cardiovascular diseases risks. However, some recent clinical trials have portrayed that this level has nothing to do with cardiovascular outcomes and triglyceride levels. Also, there have been various concerns with respect to liver problems, development of diabetes, excess infections, and excess bleeding. Hence, all these factors are collectively projected to restrict the global niacin and niacinamide market growth over the forecast period.

niacin and niacinamide market competation structure

For more insights on the niacin and niacinamide market, request for a report sample here

Niacin to Become Add-On Therapy for Management of Hyperphosphatemia in Dialysis Patients

Majority of the patients, who are affected with end-stage renal disorder, are found to develop hyperphosphatemia. These patients are, therefore, bound to oral phosphate binders to support their life-long phosphate management, along with maintenance of dialysis and dietary restrictions. A traditional antilipemic agent, niacin, is gaining traction among physicians for the treatment of hyperphosphatemia. Owing to illuminating efficacy, safety, and clinical synergistic benefits of niacin, researchers are focusing on repurposing the antilipemic agent to treat hyperphosphatemia in dialysis patients. In the upcoming years, niacin is most likely to be a cost-effective alternative and patient-convenient add-on therapy for dialysis patients’ phosphorus management. Additionally, well-designed, comparative, long-term, and large-scale clinical trials are being carried out globally for repurposing niacin in hyperphosphatemia therapeutics. 

Europe to Remain Prominent in Global Niacin and Niacinamide Market

Europe has been accounted to hold ~one fourth of the global niacin and niacinamide market revenue in 2018. Prime factors attributed to its prominence are increasing DCS incidences in dairy cattle, rising instance of childhood obesity, along with the presence of key market players and unhealthy food consumption patterns. Major portion of the European youths are witnessed to consume chocolates and carbonated or sugary drinks excessively, which led to significant increase in their body weights. Large portion of the population in the region is subjected to higher risk of obesity. Unhealthy consumption patterns and physical inactivity among individuals are some of the primary reasons behind obesity and their overweight characteristics. Hence, governments of major countries are taking efforts to push the adoption of high nutritional foods, which further drive the Europe niacin and niacinamide market growth. For reducing childhood obesity, sugar reduction programs, soft drinks industry levy, and stringent regulations on advertising junk food to children are some of the initiatives taken up by European governments. Additionally, countries in European region are facing downer cow syndrome (DCS) in dairy cattle, which results in low milk production due to reduced electrolyte metabolism. Governments, along with private institutions, are consistently focusing on spreading the awareness about benefits of niacin among dairy producers. Moreover, increasing healthcare expenditure, coupled with the presence of key players are factors that further strengthen the Europe niacin and niacinamide market. Some of the major players are Lonza Group AG, Koninklijke DSM N.V., BASF SE, Evonik Industries AG, and others.

Request research methodology of this report.

1. Global Niacin and Niacinamide Market - Executive Summary

    1.1. Summary of Key Findings

    1.2. Summary of Key Statistics

    1.3. Opportunity Assessment

    1.4. Fact.MR View Point

2. Global Niacin and Niacinamide Market Overview

    2.1. Introduction

        2.1.1. Global Niacin and Niacinamide Market Taxonomy

        2.1.2. Global Niacin and Niacinamide Market Definition

    2.2. Global Niacin and Niacinamide Market Size (US$ Mn) and Forecast, 2013-2027

        2.2.1. Global Niacin and Niacinamide Market Y-o-Y Growth

    2.3. Global Niacin and Niacinamide Market Dynamics

    2.4. Supply Chain

    2.5. Key Regulatory Bodies

    2.6. Cost Structure

    2.7. Pricing Analysis

    2.8. Manufacturing Plant Mapping

    2.9. PESTL Analysis

    2.10. Product Life Cycle Analysis

    2.11. List of Supplier

    2.12. Key Participants Market Presence (Intensity Map) By Region

3. Global Niacin and Niacinamide Market Analysis and Forecast 2013-2027 

    3.1. Global Niacin and Niacinamide Market Size and Forecast By Form 2013-2027 

        3.1.1. Powder Market Size and Forecast, 2013-2027 

            3.1.1.1. Revenue (US$ Mn) & Volume (Tons) Comparison, By Region

            3.1.1.2. Market Share Comparison, By Region

            3.1.1.3. Y-o-Y Growth Comparison, By Region

        3.1.2. Granular Market Size and Forecast, 2013-2027 

            3.1.2.1. Revenue (US$ Mn) & Volume (Tons) Comparison, By Region

            3.1.2.2. Market Share Comparison, By Region

            3.1.2.3. Y-o-Y Growth Comparison, By Region

        3.1.3. Liquid Market Size and Forecast, 2013-2027 

            3.1.3.1. Revenue (US$ Mn) & Volume (Tons) Comparison, By Region

            3.1.3.2. Market Share Comparison, By Region

            3.1.3.3. Y-o-Y Growth Comparison, By Region

    3.2. Global Niacin and Niacinamide Market Size and Forecast By End-Use, 2013-2027 

        3.2.1. Human Nutrition Market Size and Forecast, 2013-2027 

            3.2.1.1. Revenue (US$ Mn) & Volume (Tons) Comparison, By Region

            3.2.1.2. Market Share Comparison, By Region

            3.2.1.3. Y-o-Y Growth Comparison, By Region

        3.2.2. Pharmaceuticals Market Size and Forecast, 2013-2027 

            3.2.2.1. Revenue (US$ Mn) & Volume (Tons) Comparison, By Region

            3.2.2.2. Market Share Comparison, By Region

            3.2.2.3. Y-o-Y Growth Comparison, By Region

        3.2.3. Animal Nutrition Market Size and Forecast, 2013-2027 

            3.2.3.1. Revenue (US$ Mn) & Volume (Tons) Comparison, By Region

            3.2.3.2. Market Share Comparison, By Region

            3.2.3.3. Y-o-Y Growth Comparison, By Region

        3.2.4. Cosmeceuticals Market Size and Forecast, 2013-2027 

            3.2.4.1. Revenue (US$ Mn) & Volume (Tons) Comparison, By Region

            3.2.4.2. Market Share Comparison, By Region

            3.2.4.3. Y-o-Y Growth Comparison, By Region

        3.2.5. Other End-Uses Market Size and Forecast, 2013-2027 

            3.2.5.1. Revenue (US$ Mn) & Volume (Tons) Comparison, By Region

            3.2.5.2. Market Share Comparison, By Region

            3.2.5.3. Y-o-Y Growth Comparison, By Region

4. North America Niacin and Niacinamide Market Analysis 2013–2018  and Forecast 2019–2027

    4.1. Political Outlook

    4.2. Economic Outlook

    4.3. Business Environment Outlook

    4.4. North America Healthcare Sector Outlook

    4.5. North America Niacin and Niacinamide Market Analysis 2013–2018  and Forecast 2019–2027 by Country

        4.5.1. US

        4.5.2. Canada

    4.6. North America Niacin and Niacinamide Market Value (US$ Mn) and Volume (Tons) by Resin

    4.7. North America Niacin and Niacinamide Market Value (US$ Mn) and Volume (Tons) By End-Use

5. Latin America Niacin and Niacinamide Market Analysis 2013–2018  and Forecast 2019–2027

    5.1. Political Outlook

    5.2. Economic Outlook

    5.3. Business Environment Outlook

    5.4. Latin America Healthcare Sector Outlook

    5.5. Latin America Niacin and Niacinamide Market Analysis 2013–2018  and Forecast 2019–2027 by Country

        5.5.1. Brazil

        5.5.2. Mexico

        5.5.3. Rest of Latin America

    5.6. Latin America Niacin and Niacinamide Market Value (US$ Mn) and Volume (Tons) by Resin

    5.7. Latin America Niacin and Niacinamide Market Value (US$ Mn) and Volume (Tons) by End-Use

6. Europe Niacin and Niacinamide Market Analysis 2013–2018  and Forecast 2019–2027

    6.1. Political Outlook

    6.2. Economic Outlook

    6.3. Business Environment Outlook

    6.4. Europe Healthcare Sector Outlook

    6.5. Europe Niacin and Niacinamide Market Analysis 2013–2018  and Forecast 2019–2027 by Country

        6.5.1. EU-5 (Germany, UK, France, Spain, and Italy)

        6.5.2. BENELUX

        6.5.3. Nordics

        6.5.4. Eastern Europe

        6.5.5. Rest of Europe

    6.6. Europe Niacin and Niacinamide Market Value (US$ Mn) and Volume (Tons) by Resin

    6.7. Europe Niacin and Niacinamide Market Value (US$ Mn) and Volume (Tons) by End-Use

7. Japan Niacin and Niacinamide Market Analysis 2013–2018  and Forecast 2019–2027

    7.1. Political Outlook

    7.2. Economic Outlook

    7.3. Business Environment Outlook

    7.4. Japan Healthcare Sector Outlook

    7.5. Japan Niacin and Niacinamide Market Analysis 2013–2018  and Forecast 2019–2027 

    7.6. Japan Niacin and Niacinamide Market Value (US$ Mn) and Volume (Tons) by Resin

    7.7. Japan Niacin and Niacinamide Market Value (US$ Mn) and Volume (Tons) By End-Use

8. APEJ Niacin and Niacinamide Market Analysis 2013–2018  and Forecast 2019–2027

    8.1. Political Outlook

    8.2. Economic Outlook

    8.3. Business Environment Outlook

    8.4. APEJ Healthcare Sector Outlook

    8.5. APEJ Niacin and Niacinamide Market Analysis 2013–2018  and Forecast 2019–2027 by Country

        8.5.1. China

        8.5.2. India

        8.5.3. South Korea

        8.5.4. ASEAN Countries

        8.5.5. Australia & New Zealand

        8.5.6. Rest of APEJ

    8.6. APEJ Niacin and Niacinamide Market Value (US$ Mn) and Volume (Tons) by Resin

    8.7. APEJ Niacin and Niacinamide Market Value (US$ Mn) and Volume (Tons) By End-Use

9. MEA Niacin and Niacinamide Market Analysis 2013–2018  and Forecast 2019–2027

    9.1. Political Outlook

    9.2. Economic Outlook

    9.3. Business Environment Outlook

    9.4. MEA Healthcare Sector Outlook

    9.5. MEA Niacin and Niacinamide Market Value (US$ Mn) and Volume (Tons) by Country

        9.5.1. GCC Countries

        9.5.2. Turkey

        9.5.3. South Africa

        9.5.4. North Africa

        9.5.5. Rest of MEA

    9.6. MEA Niacin and Niacinamide Market Value (US$ Mn) and Volume (Tons) by Resin

    9.7. MEA Niacin and Niacinamide Market Value (US$ Mn) and Volume (Tons) By End-Use

10. Competitive Assessment

    10.1. Global Niacin and Niacinamide Market Structure

    10.2. Global Niacin and Niacinamide Market Competition - a Dashboard View

    10.3. Global Niacin and Niacinamide Market Company Share Analysis

    10.4. Key Participants Market Presence (Intensity Mapping) by Region

11. Company Profiles

    11.1. Bactolac Pharmaceutical Inc.

        11.1.1. Company Overview

        11.1.2. Product Overview

        11.1.3. Key Financials

        11.1.4. Key Developments

        11.1.5. SWOT Analysis

    11.2. BASF SE

        11.2.1. Company Overview

        11.2.2. Product Overview

        11.2.3. Key Financials

        11.2.4. Key Developments

        11.2.5. SWOT Analysis

    11.3. Brother Enterprises Holding Co., Ltd.

        11.3.1. Company Overview

        11.3.2. Product Overview

        11.3.3. Key Financials

        11.3.4. SWOT Analysis

    11.4. Evonik Industries AG

        11.4.1. Company Overview

        11.4.2. Product Overview

        11.4.3. Key Financials

        11.4.4. SWOT Analysis

    11.5. Fagron NV

        11.5.1. Company Overview

        11.5.2. Product Overview

    11.6. Foodchem International Corporation

        11.6.1. Company Overview

        11.6.2. Product Overview

        11.6.3. SWOT Analysis

    11.7. Jubilant Life Sciences Limited

        11.7.1. Company Overview

        11.7.2. Product Overview

        11.7.3. Key Financials

        11.7.4. Key Developments

    11.8. Koninklijke DSM N.V.

        11.8.1. Company Overview

        11.8.2. Product Overview

        11.8.3. Key Financials

        11.8.4. SWOT Analysis

    11.9. Lonza Group AG

        11.9.1. Company Overview

        11.9.2. Product Overview

        11.9.3. Key Financials

        11.9.4. Key Developments

        11.9.5. SWOT Analysis

    11.10. Merck KGaA

        11.10.1. Company Overview

        11.10.2. Product Overview

        11.10.3. Key Financials

        11.10.4. Key Developments

        11.10.5. SWOT Analysis

    11.11. Vertellus Specialties Inc.

        11.11.1. Company Overview

        11.11.2. Product Overview

        11.11.3. Key Financials

        11.11.4. Key Developments

        11.11.5. SWOT Analysis

    11.12. Zhejiang NHU Company Ltd.

        11.12.1. Company Overview

        11.12.2. Product Overview

        11.12.3. Key Financials

        11.12.4. Key Developments

        11.12.5. SWOT Analysis

12. FMI Research Methodology

13. Disclaimer

List of Tables

TABLE 1 Global Niacin and Niacinamide Market Value (US$ Mn), 2013-2018

TABLE 2 Global Niacin and Niacinamide Market Value (US$ Mn), 2019-2027

TABLE 3 Global Niacin and Niacinamide Market Value (US$ Mn) and Y-o-Y, 2019-2027

TABLE 4 Global Powder Segment Value (US$ Mn), By Region 2013-2018

TABLE 5 Global Powder Segment Volume (Tons), By Region 2013-2018

TABLE 6 Global Powder Segment Value (US$ Mn), By Region 2019-2027

TABLE 7 Global Powder Segment Volume (Tons), By Region 2019-2027

TABLE 8 Global Powder Segment Market Share, By Region 2013-2018

TABLE 9 Global Powder Segment Market Share, By Region 2019-2027

TABLE 10 Global Powder Segment Y-o-Y, By Region 2019-2027

TABLE 11 Global Granular Segment Value (US$ Mn), By Region 2013-2018

TABLE 12 Global Granular Segment Volume (Tons), By Region 2013-2018

TABLE 13 Global Granular Segment Value (US$ Mn), By Region 2019-2027

TABLE 14 Global Granular Segment Volume (Tons), By Region 2019-2027

TABLE 15 Global Granular Segment Market Share, By Region 2013-2018

TABLE 16 Global Granular Segment Market Share, By Region 2019-2027

TABLE 17 Global Granular Segment Y-o-Y, By Region 2019-2027

TABLE 18 Global Liquid Segment Value (US$ Mn), By Region 2013-2018

TABLE 19 Global Liquid Segment Volume (Tons), By Region 2013-2018

TABLE 20 Global Liquid Segment Value (US$ Mn), By Region 2019-2027

TABLE 21 Global Liquid Segment Volume (Tons), By Region 2019-2027

TABLE 22 Global Liquid Segment Market Share, By Region 2013-2018

TABLE 23 Global Liquid Segment Market Share, By Region 2019-2027

TABLE 24 Global Liquid Segment Y-o-Y, By Region 2019-2027

TABLE 25 Global Human Nutrition Segment Value (US$ Mn), By Region 2013-2018

TABLE 26 Global Human Nutrition Segment Volume (Tons), By Region 2013-2018

TABLE 27 Global Human Nutrition Segment Value (US$ Mn), By Region 2019-2027

TABLE 28 Global Human Nutrition Segment Volume (Tons), By Region 2019-2027

TABLE 29 Global Human Nutrition Segment Market Share, By Region 2013-2018

TABLE 30 Global Human Nutrition Segment Market Share, By Region 2019-2027

TABLE 31 Global Human Nutrition Segment Y-o-Y, By Region 2019-2027

TABLE 32 Global Pharmaceuticals Segment Value (US$ Mn), By Region 2013-2018

TABLE 33 Global Pharmaceuticals Segment Volume (Tons), By Region 2013-2018

TABLE 34 Global Pharmaceuticals Segment Value (US$ Mn), By Region 2019-2027

TABLE 35 Global Pharmaceuticals Segment Volume (Tons), By Region 2019-2027

TABLE 36 Global Pharmaceuticals Segment Market Share, By Region 2013-2018

TABLE 37 Global Pharmaceuticals Segment Market Share, By Region 2019-2027

TABLE 38 Global Pharmaceuticals Segment Y-o-Y, By Region 2019-2027

TABLE 39 Global Animal Nutrition Segment Value (US$ Mn), By Region 2013-2018

TABLE 40 Global Animal Nutrition Segment Volume (Tons), By Region 2013-2018

TABLE 41 Global Animal Nutrition Segment Value (US$ Mn), By Region 2019-2027

TABLE 42 Global Animal Nutrition Segment Volume (Tons), By Region 2019-2027

TABLE 43 Global Animal Nutrition Segment Market Share, By Region 2013-2018

TABLE 44 Global Animal Nutrition Segment Market Share, By Region 2019-2027

TABLE 45 Global Animal Nutrition Segment Y-o-Y, By Region 2019-2027

TABLE 46 Global Cosmeceuticals Segment Value (US$ Mn), By Region 2013-2018

TABLE 47 Global Cosmeceuticals Segment Volume (Tons), By Region 2013-2018

TABLE 48 Global Cosmeceuticals Segment Value (US$ Mn), By Region 2019-2027

TABLE 49 Global Cosmeceuticals Segment Volume (Tons), By Region 2019-2027

TABLE 50 Global Cosmeceuticals Segment Market Share, By Region 2013-2018

TABLE 51 Global Cosmeceuticals Segment Market Share, By Region 2019-2027

TABLE 52 Global Cosmeceuticals Segment Y-o-Y, By Region 2019-2027

TABLE 53 Global Others Segment Value (US$ Mn), By Region 2013-2018

TABLE 54 Global Others Segment Volume (Tons), By Region 2013-2018

TABLE 55 Global Others Segment Value (US$ Mn), By Region 2019-2027

TABLE 56 Global Others Segment Volume (Tons), By Region 2019-2027

TABLE 57 Global Others Segment Market Share, By Region 2013-2018

TABLE 58 Global Others Segment Market Share, By Region 2019-2027

TABLE 59 Global Others Segment Y-o-Y, By Region 2019-2027

TABLE 60 North America Current Expenditure on Health, (% of GDP), by Country, 2010 – 2016

TABLE 61 North America Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016

TABLE 62 North America Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016

TABLE 63 North America Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016

TABLE 64 North America Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016

TABLE 65 North America Niacin and Niacinamide Market Value (US$ Mn), By Country 2013-2018

TABLE 66 North America Niacin and Niacinamide Market Volume (Tons), By Country 2013-2018

TABLE 67 North America Niacin and Niacinamide Market Value (US$ Mn), By Country 2019-2027

TABLE 68 North America Niacin and Niacinamide Market Volume (Tons), By Country 2019-2027

TABLE 69 North America Niacin and Niacinamide Market Value (US$ Mn), By Form 2013-2018

TABLE 70 North America Niacin and Niacinamide Market Value (US$ Mn), By Form 2019-2027

TABLE 71 North America Niacin and Niacinamide Market Value (US$ Mn), By End Use 2013-2018

TABLE 72 North America Niacin and Niacinamide Market Value (US$ Mn), By End Use 2019-2027

TABLE 73 Latin America Current Expenditure on Health, (% of GDP), by Country, 2010 – 2016

TABLE 74 Latin America Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016

TABLE 75 Latin America Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016

TABLE 76 Latin America Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016

TABLE 77 Latin America Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016

TABLE 78 Latin America Niacin and Niacinamide Market Value (US$ Mn), By Country 2013-2018

TABLE 79 Latin America Niacin and Niacinamide Market Volume (Tons), By Country 2013-2018

TABLE 80 Latin America Niacin and Niacinamide Market Value (US$ Mn), By Country 2019-2027

TABLE 81 Latin America Niacin and Niacinamide Market Volume (Tons), By Country 2019-2027

TABLE 82 Latin America Niacin and Niacinamide Market Value (US$ Mn), By Form 2013-2018

TABLE 83 Latin America Niacin and Niacinamide Market Value (US$ Mn), By Form 2019-2027

TABLE 84 Latin America Niacin and Niacinamide Market Value (US$ Mn), By End Use 2013-2018

TABLE 85 Latin America Niacin and Niacinamide Market Value (US$ Mn), By End Use 2019-2027

TABLE 86 Europe Current Expenditure on Health, (% of GDP), by Country, 2010 – 2016

TABLE 87 Europe Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016

TABLE 88 Europe Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016

TABLE 89 Europe Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016

TABLE 90 Europe Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016

TABLE 91 Europe Niacin and Niacinamide Market Value (US$ Mn), By Country 2013-2018

TABLE 92 Europe Niacin and Niacinamide Market Volume (Tons), By Country 2013-2018

TABLE 93 Europe Niacin and Niacinamide Market Value (US$ Mn), By Country 2019-2027

TABLE 94 Europe Niacin and Niacinamide Market Volume (Tons), By Country 2019-2027

TABLE 95 Europe Niacin and Niacinamide Market Value (US$ Mn), By Form 2013-2018

TABLE 96 Europe Niacin and Niacinamide Market Value (US$ Mn), By Form 2019-2027

TABLE 97 Europe Niacin and Niacinamide Market Value (US$ Mn), By End Use 2013-2018

TABLE 98 Europe Niacin and Niacinamide Market Value (US$ Mn), By End Use 2019-2027

TABLE 99 Japan Current Expenditure on Health, (% of GDP), by Country, 2010 – 2016

TABLE 100 Japan Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016

TABLE 101 Japan Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016

TABLE 102 Japan Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016

TABLE 103 Japan Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016

TABLE 104 Japan Niacin and Niacinamide Market Value (US$ Mn), By Country 2013-2018

TABLE 105 Japan Niacin and Niacinamide Market Volume (Tons), By Country 2013-2018

TABLE 106 Japan Niacin and Niacinamide Market Value (US$ Mn), By Country 2019-2027

TABLE 107 Japan Niacin and Niacinamide Market Volume (Tons), By Country 2019-2027

TABLE 108 Japan Niacin and Niacinamide Market Value (US$ Mn), By Form 2013-2018

TABLE 109 Japan Niacin and Niacinamide Market Value (US$ Mn), By Form 2019-2027

TABLE 110 Japan Niacin and Niacinamide Market Value (US$ Mn), By End Use 2013-2018

TABLE 111 Japan Niacin and Niacinamide Market Value (US$ Mn), By End Use 2019-2027

TABLE 112 APEJ Current Expenditure on Health, (% of GDP), by Country, 2010 – 2016

TABLE 113 APEJ Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016

TABLE 114 APEJ Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016

TABLE 115 APEJ Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016

TABLE 116 APEJ Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016

TABLE 117 APEJ Niacin and Niacinamide Market Value (US$ Mn), By Country 2013-2018

TABLE 118 APEJ Niacin and Niacinamide Market Volume (Tons), By Country 2013-2018

TABLE 119 APEJ Niacin and Niacinamide Market Value (US$ Mn), By Country 2019-2027

TABLE 120 APEJ Niacin and Niacinamide Market Volume (Tons), By Country 2019-2027

TABLE 121 APEJ Niacin and Niacinamide Market Value (US$ Mn), By Form 2013-2018

TABLE 122 APEJ Niacin and Niacinamide Market Value (US$ Mn), By Form 2019-2027

TABLE 123 APEJ Niacin and Niacinamide Market Value (US$ Mn), By End Use 2013-2018

TABLE 124 APEJ Niacin and Niacinamide Market Value (US$ Mn), By End Use 2019-2027

TABLE 125 MEA Current Expenditure on Health, (% of GDP), by Country, 2010 – 2016

TABLE 126 MEA Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016

TABLE 127 MEA Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016

TABLE 128 MEA Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016

TABLE 129 MEA Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016

TABLE 130 MEA Niacin and Niacinamide Market Value (US$ Mn), By Country 2013-2018

TABLE 131 MEA Niacin and Niacinamide Market Volume (Tons), By Country 2013-2018

TABLE 132 MEA Niacin and Niacinamide Market Value (US$ Mn), By Country 2019-2027

TABLE 133 MEA Niacin and Niacinamide Market Volume (Tons), By Country 2019-2027

TABLE 134 MEA Niacin and Niacinamide Market Value (US$ Mn), By Form 2013-2018

TABLE 135 MEA Niacin and Niacinamide Market Value (US$ Mn), By Form 2019-2027

TABLE 136 MEA Niacin and Niacinamide Market Value (US$ Mn), By End Use 2013-2018

TABLE 137 MEA Niacin and Niacinamide Market Value (US$ Mn), By End Use 2019-2027

List of Figures

FIG. 1 Global Niacin and Niacinamide Market Value (US$ Mn), 2013-2018

FIG. 2 Global Niacin and Niacinamide Market Value (US$ Mn) Forecast, 2019-2027

FIG. 3 Global Niacin and Niacinamide Market Value (US$ Mn) and Y-o-Y, 2019-2027

FIG. 4 Global Powder Segment Market Value (US$ Mn) By Region, 2013-2018

FIG. 5 Global Powder Segment Market Value (US$ Mn) By Region, 2019-2027

FIG. 6 Global Powder Segment Y-o-Y Growth Rate, By Region, 2019-2027

FIG. 7 Global Granular Segment Market Value (US$ Mn) By Region, 2013-2018

FIG. 8 Global Granular Segment Market Value (US$ Mn) By Region, 2019-2027

FIG. 9 Global Granular Segment Y-o-Y Growth Rate, By Region, 2019-2027

FIG. 10 Global Liquid Segment Market Value (US$ Mn) By Region, 2013-2018

FIG. 11 Global Liquid Segment Market Value (US$ Mn) By Region, 2019-2027

FIG. 12 Global Liquid Segment Y-o-Y Growth Rate, By Region, 2019-2027

FIG. 13 Global Human Nutrition Segment Market Value (US$ Mn) By Region, 2013-2018

FIG. 14 Global Human Nutrition Segment Market Value (US$ Mn) By Region, 2019-2027

FIG. 15 Global Human Nutrition Segment Y-o-Y Growth Rate, By Region, 2019-2027

FIG. 16 Global Pharmaceuticals Segment Market Value (US$ Mn) By Region, 2013-2018

FIG. 17 Global Pharmaceuticals Segment Market Value (US$ Mn) By Region, 2019-2027

FIG. 18 Global Pharmaceuticals Segment Y-o-Y Growth Rate, By Region, 2019-2027

FIG. 19 Global Animal Nutrition Segment Market Value (US$ Mn) By Region, 2013-2018

FIG. 20 Global Animal Nutrition Segment Market Value (US$ Mn) By Region, 2019-2027

FIG. 21 Global Animal Nutrition Segment Y-o-Y Growth Rate, By Region, 2019-2027

FIG. 22 Global Cosmeceuticals Segment Market Value (US$ Mn) By Region, 2013-2018

FIG. 23 Global Cosmeceuticals Segment Market Value (US$ Mn) By Region, 2019-2027

FIG. 24 Global Cosmeceuticals Segment Y-o-Y Growth Rate, By Region, 2019-2027

FIG. 25 Global Others Segment Market Value (US$ Mn) By Region, 2013-2018

FIG. 26 Global Others Segment Market Value (US$ Mn) By Region, 2019-2027

FIG. 27 Global Others Segment Y-o-Y Growth Rate, By Region, 2019-2027

FIG. 28 North America Niacin and Niacinamide Market Value (US$ Mn), By Country 2013-2018

FIG. 29 North America Niacin and Niacinamide Market Value (US$ Mn), By Country 2019-2027

FIG. 30 North America Niacin and Niacinamide Market Value (US$ Mn), By Form 2013-2018

FIG. 31 North America Niacin and Niacinamide Market Value (US$ Mn), By Form 2019-2027

FIG. 32 North America Niacin and Niacinamide Market Value (US$ Mn), By End Use 2013-2018

FIG. 33 North America Niacin and Niacinamide Market Value (US$ Mn), By End Use 2019-2027

FIG. 34 Latin America Niacin and Niacinamide Market Value (US$ Mn), By Country 2013-2018

FIG. 35 Latin America Niacin and Niacinamide Market Value (US$ Mn), By Country 2019-2027

FIG. 36 Latin America Niacin and Niacinamide Market Value (US$ Mn), By Form 2013-2018

FIG. 37 Latin America Niacin and Niacinamide Market Value (US$ Mn), By Form 2019-2027

FIG. 38 Latin America Niacin and Niacinamide Market Value (US$ Mn), By End Use 2013-2018

FIG. 39 Latin America Niacin and Niacinamide Market Value (US$ Mn), By End Use 2019-2027

FIG. 40 Europe Niacin and Niacinamide Market Value (US$ Mn), By Country 2013-2018

FIG. 41 Europe Niacin and Niacinamide Market Value (US$ Mn), By Country 2019-2027

FIG. 42 Europe Niacin and Niacinamide Market Value (US$ Mn), By Form 2013-2018

FIG. 43 Europe Niacin and Niacinamide Market Value (US$ Mn), By Form 2019-2027

FIG. 44 Europe Niacin and Niacinamide Market Value (US$ Mn), By End Use 2013-2018

FIG. 45 Europe Niacin and Niacinamide Market Value (US$ Mn), By End Use 2019-2027

FIG. 46 Japan Niacin and Niacinamide Market Value (US$ Mn), By Country 2013-2018

FIG. 47 Japan Niacin and Niacinamide Market Value (US$ Mn), By Country 2019-2027

FIG. 48 Japan Niacin and Niacinamide Market Value (US$ Mn), By Form 2013-2018

FIG. 49 Japan Niacin and Niacinamide Market Value (US$ Mn), By Form 2019-2027

FIG. 50 Japan Niacin and Niacinamide Market Value (US$ Mn), By 2013-2018

FIG. 51 Japan Niacin and Niacinamide Market Value (US$ Mn), By End Use 2019-2027

FIG. 52 APEJ Niacin and Niacinamide Market Value (US$ Mn), By Country 2013-2018

FIG. 53 APEJ Niacin and Niacinamide Market Value (US$ Mn), By Country 2019-2027

FIG. 54 APEJ Niacin and Niacinamide Market Value (US$ Mn), By Form 2013-2018

FIG. 55 APEJ Niacin and Niacinamide Market Value (US$ Mn), By Form 2019-2027

FIG. 56 APEJ Niacin and Niacinamide Market Value (US$ Mn), By End Use 2013-2018

FIG. 57 APEJ Niacin and Niacinamide Market Value (US$ Mn), By End Use 2019-2027

FIG. 58 MEA Niacin and Niacinamide Market Value (US$ Mn), By Country 2013-2018

FIG. 59 MEA Niacin and Niacinamide Market Value (US$ Mn), By Country 2019-2027

FIG. 60 MEA Niacin and Niacinamide Market Value (US$ Mn), By Form 2013-2018

FIG. 61 MEA Niacin and Niacinamide Market Value (US$ Mn), By Form 2019-2027

FIG. 62 MEA Niacin and Niacinamide Market Value (US$ Mn), By End Use 2013-2018

FIG. 63 MEA Niacin and Niacinamide Market Value (US$ Mn), By End Use 2019-2027

Fact.MR offers custom research services that help clients to get specific research solutions

We are committed towards customer satisfaction and quality service.


Our Clients

Malaysian Cocoa Board
Dunlop International Europe Ltd
Roland Berger
Superior Essex
Commscope
Deloitte

Fact.MR in Media

Niacin and Niacinamide Market Forecast, Trend Analysis & Competition Tracking - Global Market Insights 2019 to 2027